Pediatr. praxi. 2023;24(4):274-278

Prevention and therapy of influenza conditions: some modalities

MUDr. Pavel Kostiuk, CSc.1, PharmDr. Lucie Kotlářová2, PharmDr. Zdeněk Procházka1
1 Edukafarm, Jesenice u Prahy
2 InPharm Clinic, Jesenice u Prahy

Viral respiratory diseases (regardless of the type of the causing virus), which are manifested by a clinical picture resembling influenza (high temperature, cough, sore throat) are referred to as "influenza-like illness" (ILI), or flu conditions. Treatment of these diseases is usually symptomatic (except for antiviral drugs that can be used for "true" flu). Due to the dominant role of the state of the immune system in the development and course of these diseases, immunostimulation has a dominant position in prevention and treatment. One possibility is the flu vaccination, but this only targets the "true" flu, while not affecting the risk of other ILIs. Therefore, it is necessary to look for other options for supporting the immune system against these diseases. In the article, we focus on two possibilities of immunostimulation, intended for the prevention and treatment of influenza-like illness.

Keywords: immunomodulation, immunostimulation, prevention and therapy of influenza-like illness.

Published: September 8, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kostiuk P, Kotlářová L, Procházka Z. Prevention and therapy of influenza conditions: some modalities. Pediatr. praxi. 2023;24(4):274-278.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Spencer JA, Shutt DP, Moser SK, et al. Distinguishing viruses responsible for influenza-like illness. J Theor Biol. 2022; 545:111145. Go to original source...
    2. Mousa HAL. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med. 2017;22:166-174. Go to original source...
    3. Boženský J, Kopřiva F, Kotlářová J, et al. Některé možnosti prevence a léčby chřipkovitých onemocnění. Pediatr Praxi. 2022;23:361-365. Go to original source...
    4. Marrari LA, Terzan L, Chaufferin G. Anas barbariae for influenza treatment. Ann Ist Super Sanita. 2012;48:105-109. Go to PubMed...
    5. Casanova P, Gerard R, Bilan DE. 3 années d´études randomisées multicentriques Anas barbariae/placebo. Proposta Omeopatica. 1988;6:14-17.
    6. Ferley JP, Zmirou D, D´Adhemar D, et al. A controlled evaluation of a homeopathic preparation in the treatment of inluenza-like syndromes. Br J Clin Pharmacol. 1989;27:329-335. Go to original source...
    7. Papp R, Schuback G, Beck E, et al. Anas barbariae in patients with influenza-like syndromes: a placebo controlled double blind evaluation. Br Homeopath J. 1998;87:69-76. Go to original source...
    8. Colombo M, Rigamonti G, Danza ML, et al. Comparative evaluation of Guna-Flu vs vaccine for the prevention of influenza syndrome in paediatrics - A prospective, multicentric randomized, controlled clinical trial. Physiological Regulating Medicine. 2007;2(1):3-10.
    9. Supino C. Prevenzione delle infezioni delle alte vie respiratporie in eta pediatrica con Omeogriphi: studio multicentrico controllato. La Medicina Biologica. 2002;20(3):19-23.
    10. Arrighi A. Omeogriphi vs. paracetamolo nel trattamento della sindrome influenzale - studio clinico prosperrico controllato. La Medicina Biologica. 2013;31(4):3-12.
    11. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9:1211. Go to original source...
    12. Vollbracht C, Raithel M, Krick B, et al. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study. J Int Med Res. 2018;46:3640-3655. Go to original source...
    13. Hagel AF, Layritz CM, Hagel WH, et al. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol. 2014;386:789-793. Go to original source...
    14. Tardy AL, Pouteau E, Marquez D. Vitamins and minerals for energy, fatigue and cognition: A narrative review of biochemical and clinical evidence. Nutrients. 2020;12:228. Go to original source...
    15. Bakaev VV, Duntau AP. Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia. Int J Tuberc Lung Dis. 2004;8:263-266. Go to PubMed...
    16. Hunt C, Chakravorty NK, Annan G, et al. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res. 1994;64:212-219.
    17. Uesato S, Kitagawa Y, Kaijima T, et al. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight - or branched-acyl chain on Epstein-Barr virus activation. Cancer Lett. 2001;166:143-146. Go to original source...
    18. Cinatl J, Cinatl J, Weber B, et al. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Anti­viral Res. 1995;27:405-418. Go to original source...
    19. Leibovitz B, Siegel BV. Ascorbic acid and the immune response. Adv Exp Med Biol. 1981;135:1-25. Go to original source...
    20. Dey S, Bishayi B. Killing of S. aureus in murine peritoneal macrophages by ascorbic acid along with antibiotics chloramphenicol or ofloxacin: correlation with inflammation. Microb Pathog. 2018;115:239-250. Go to original source... Go to PubMed...
    21. Kim Y, Kim H, Bae S, et al. Vitamin C is an essential factor on the anti-viral immune response through the production of interferon-alpha/beta at the initial stage of influenza A virus (H3N2) infection. Immune Netw. 2013;13:70-74. Go to original source... Go to PubMed...
    22. Li W, Maeda N, Beck MA. Vitamin C deficiency increases the lung pathology of influenza virus-infected gulo-/- mice. J Nutr. 2006;136:2611-2616. Go to original source...
    23. Cai Y, Li YF, Tang LP, et al. A new mechanism of vitamin C effects on A/FM/1/47(H1N1) virus-induced pneumonia in restraint-stressed mice. Biomed Res Int. 2015;2015:675149. Go to original source... Go to PubMed...
    24. Kataoka A, Imai H, Inayoshi S, et al. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psy. 1993;56:1213-1216. Go to original source...
    25. Harakeh S. NF-kappa B-independent suppression of HIV expression by ascorbic acid. AIDS Res Hum Retroviruses. 1997;13:235-239. Go to original source... Go to PubMed...
    26. Hosakote YM, Jantzi PD, Esham DL, et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2011;183:1550-1560. Go to original source...
    27. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537. Go to original source...
    28. Ahn H, Park JH. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016;20:36. Go to original source...
    29. Fan C, Pacier C, Martirosyan DM. Rose hip (Rosa canina L): A functional food perspective. Funct Foods Health Dis. 2014;4:493-509. Go to original source...
    30. Boženský J, Kotlářová L, Kostiuk P. Zkušenosti se suplementací vitaminu C s lipozomálním vstřebáváním u dětí. Biotherapeutics. 2022;12:34-35.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.